Altria (DE:PHM7)
NYSE:PHM7
PHM7 Stock Chart & Stats
€54.48
-€0.17(-0.33%)
At close: 4:00 PM EST
€54.48
-€0.17(-0.33%)
Day’s Range― - ―
52-Week Range€46.62 - €64.08
Previous CloseN/A
Volume2.27K
Average Volume (3M)3.07K
Market Cap
€105.70B
Enterprise Value€137.26B
Total Cash (Recent Filing)€3.53B
Total Debt (Recent Filing)€24.60B
Price to Earnings (P/E)15.2
Beta0.09
Next Earnings
Jul 30, 2026EPS Estimate
1.29Next Dividend Ex-DateN/A
Dividend Yield7.26%
Share Statistics
EPS (TTM)4.78
Shares Outstanding1,669,891,200
10 Day Avg. Volume1,981
30 Day Avg. Volume3,070
Financial Highlights & Ratios
PEG Ratio-0.37
Price to Book (P/B)-27.61
Price to Sales (P/S)4.80
P/FCF Ratio10.66
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€62.10Price Target Upside13.99% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)4.88
Revenue Forecast (FY)€17.61B
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow GenerationConsistent, very large FCF provides durable funding for dividends, buybacks and debt paydowns, enabling capital returns while supporting strategic investments. High cash conversion improves resilience to volume weakness and underpins financial policy over the next several quarters.
High Smokeable Margins & Pricing PowerVery high smokeable margins and demonstrated net price realization show the business can offset secular volume declines via pricing and mix. That persistent margin advantage supports profitability and cash flow stability in a mature, shrinking category over the medium term.
On! Nicotine-pouch Growth And National RolloutRapid shipment growth and broad retail distribution for on! products represent a structural expansion into modern oral nicotine. National rollout and rising pouch mix diversify revenue away from cigarettes and create a durable growth avenue as consumer preferences evolve.
Bears Say
Elevated Leverage And Negative EquitySubstantial debt and negative shareholder equity constrain financial flexibility, raising refinancing and covenant risk and limiting strategic optionality. In a downturn or with adverse cash trends, elevated leverage could force tougher tradeoffs between returns, investment and deleveraging.
Cigarette Volume And Marlboro Share PressureOngoing combustible volume declines and erosion in Marlboro retail share are structural threats to core revenue. Persistent trade‑down to discount brands and market share slip reduce long‑term top‑line resilience and increase dependence on pricing and cost control to sustain profits.
Oral-tobacco Headwinds And Illicit E‑vapor DisruptionDeclining oral volumes, margin compression from marketing and product mix, plus a heavily illicit e‑vapor market, limit growth conversion in harm‑reduction categories. These structural obstacles could slow sustainable share gains in pouches and delay migration from combustible products.
Altria Group News
PHM7 FAQ
What was Altria’s price range in the past 12 months?
Altria lowest stock price was €46.62 and its highest was €64.08 in the past 12 months.
What is Altria’s market cap?
Altria’s market cap is €105.70B.
When is Altria’s upcoming earnings report date?
Altria’s upcoming earnings report date is Jul 30, 2026 which is in 48 days.
How were Altria’s earnings last quarter?
Altria released its earnings results on Apr 30, 2026. The company reported €1.143 earnings per share for the quarter, beating the consensus estimate of €1.078 by €0.064.
Is Altria overvalued?
According to Wall Street analysts Altria’s price is currently Undervalued.
Does Altria pay dividends?
Altria pays a Quarterly dividend of €0.919 which represents an annual dividend yield of 7.26%. See more information on Altria dividends here
What is Altria’s EPS estimate?
Altria’s EPS estimate is 1.29.
How many shares outstanding does Altria have?
Altria has 1,669,891,200 shares outstanding.
What happened to Altria’s price movement after its last earnings report?
Altria reported an EPS of €1.143 in its last earnings report, beating expectations of €1.078. Following the earnings report the stock price went up 6.005%.
Which hedge fund is a major shareholder of Altria?
Currently, no hedge funds are holding shares in DE:PHM7
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Altria Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€62.10 (13.99% Upside)
€62.10 (13.99% Upside)
Blogger Sentiment
Bullish
DE:PHM7 Sentiment 70%
Sector Average ―
Sector Average ―
Insider Transactions
Sold Shares
Worth €1.6M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
33.66%
12-Months-Change
Fundamentals
Return on Equity
-255.35%
Trailing 12-Months
Asset Growth
-3.29%
Trailing 12-Months
Company Description
Altria
Operating across the United States through its subsidiaries, Altria Group, Inc. is a prominent manufacturer and marketer of both combustible and oral tobacco items. Its portfolio features cigarettes, primarily under the iconic Marlboro brand, alongside cigars and pipe tobacco mainly offered as Black & Mild. The enterprise further provides an assortment of moist smokeless tobacco products, including Copenhagen, Skoal, Red Seal, and Husky, in addition to its on! brand of oral nicotine pouches. Altria distributes its merchandise chiefly to wholesale partners, such as independent distributors, and directly to substantial retail organizations, including major chain stores. The corporation, founded in 1822, maintains its principal offices in Richmond, Virginia.
PHM7 Company Deck
PHM7 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: operational and financial strengths (7.3% adjusted EPS growth, strong smokeable segment margins, on! shipment growth and national rollout, ABI earnings growth, robust dividends and buybacks, and a solid balance sheet) were balanced against meaningful headwinds (notably sizable adjusted declines in Oral Tobacco volumes and retail share, cigarette volume declines, Marlboro retail share pressure and persistent illicit e-vapor market issues). Management’s reaffirmed but modest full-year guidance and emphasis on macro uncertainty underscore a cautious tone despite strong cash generation and execution in key areas.View all DE:PHM7 earnings summariesPHM7 Revenue Breakdown
88.00% Smokeable products
12.04% Oral tobacco products
-0.06% E-vapor products
0.02% All other
PHM7 Stock 12 Month Forecast
Average Price Target
€62.10
▲(13.99% Upside)
Technical Analysis
British American Tobacco
―
Philip Morris
―
Universal
―
Turning Point Brands
―
RLX Technology
―
Options Prices
Currently, No data available
---